Risk factors for deep candida infections in liver transplant recipients.
Tollemar
J
J
Department of Transplantation Surgery, Huddinge Hospital, Stockholm, Sweden.
Ericzon
B G
BG
Barkholt
L
L
Andersson
J
J
Ringdén
O
O
Groth
C G
CG
D000704:Analysis of Variance; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002177:Candidiasis / Q000209:etiology*; D003422:Critical Care; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007902:Length of Stay; D016031:Liver Transplantation / Q000009:adverse effects*; D016853:Muromonab-CD3; D012044:Regression Analysis; D012307:Risk Factors
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016853:Muromonab-CD3